Introduction
MHC Class II molecules are constitutively expressed on specialised antigen-presenting cells (APCs) such as dendritic cells (DCs) and macrophages. Antigen presentation by such cells to T cells results in T cell proliferation and differentiation towards effector function. However, MHC class II expression can be induced on multiple other cell types under the influence of cytokines such as gamma interferon (1, 2, 3) . The consequences of antigen presentation by such non-specialised APC remain unclear. Most of the cell types on which MHC class II expression can be induced do not express the major costimulatory molecules CD80 and CD86. Using gamma interferon-treated primary cultures of human epithelial cells, we have previously reported the induction of antigenspecific unresponsiveness in human CD4 + T cells (2) . In most species, T cells themselves express MHC class II molecules following activation (4, 5, 6) . Antigen presentation by activated T cells to activated T cells has been reported by several groups to induce either T cell anergy or apoptosis (7, 8, 9, 10, 11, 12). Indeed, the first report of antigen-induced unresponsiveness resulted from the culture of a human T cell clone with its cognate peptide in the absence of added APC (7). Mechanistically this is a conundrum in that activated T cells also express substantial levels of B7 family co-stimulatory molecules (13, 14, 15). However, the regulatory effects of T:T antigen presentation may have a biological role in limiting clonal expansion at the later stages of an immune response. One species in which T cells do not synthesise MHC class II molecules is the mouse (16, 17) . It has been assumed therefore that CD4 + T:T presentation does not apply in this species. However there have been several recent reports describing the acquisition of molecules by T cells from APC. These have included the transfer of MHC class I only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From molecules (18, 19) , B7 family molecules (20, 21) and MHC class II molecules in a series of rat experiments (22, 23, 24) . The earliest description of MHC class II molecule transfer came from electron microsocopy studies of thymocytes in irradiation chimaeras (25) and studies with T cell clones in vitro (26).
In this study we have examined the capacity of T cell receptor-transgenic and T hybridoma cells to acquire MHC II:peptide complexes from APC and subsequently present them to other T cells. The functional consequences of these events suggest that T:T antigen presentation may serve to limit T cell clonal expansion. The relevance of these findings to alloimmunity following tissue and stem cell transplantation is discussed. . DAP.3-H2-A k transfectants have been generated in our laboratory. CTLL2 is a murine IL-2 dependent CD8 + cell line for the detection of IL-2 production. T cells were maintained in RPMI 1640 supplemented with 10% FCS, 2mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 5 x10 -5 M 2-ME. DAP.3 transfectants were maintained in DMEM supplemented with 10% FCS, 2mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 5 x10 -5 M 2-ME with appropriate drug selection to maintain expression of the transfected genes. If the acquired MHC II:peptide complexes were to be of any functional significance in vivo they would need to be stably expressed. The rate of decay of serologically detectable MHC class II molecules was assessed by culturing the sorted CD4 + T cells after MHC class II acquisition for varying time periods. As shown in Table 1 the percentage positive cells and the mean fluorescence intensity did decay over time.
However readily detectable MHC class II expression was observed as much as 18 hrs after in vitro culture.
CD4 + T cells acquire MHC Class II molecules in vivo.
When staining freshly isolated ex-vivo CD4 + T cells from DO11.10 mice, we had consistently noticed a low level of staining with anti-MHC class II antibody which we only.
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From interpreted as non-specific background activity. However, having observed the above results we tested the possibility that this was genuine MHC II expression on the T cells due to acquisition in vivo. In order to address this, the T cells were either analysed immediately following purification or after 24 hrs of culture in the absence of APC. As shown in figure 2A For Taken together these data suggest that mouse CD4 + T cells acquire MHC II:peptide complexes from APC, can present these to each other, and that such T:T antigen presentation can induce both apoptosis and hyporesponsiveness.
only.
For
Discussion
The first observation of T cell anergy was made when a human T cell clone was There have been numerous reports of the transfer of molecules from APC to T cells, in mouse and rat systems. The first such observations were made using immuno-electron microscopic analysis of mouse thymic sections, in which murine thymocytes were noted to express MHC class II molecules, presumably acquired from thymic epithelium (25).
More recently the capture of MHC class I and class II molecules by mouse and rat T cells from APC have been described (18, 19, 22, 23, 24) . Additional reports of the transfer of costimulatory molecules from APC to T cells have been made (20, 21) . Indeed, such acquired MHC:peptide complexes appeared to be functional, in that CD8 + T cells became sensitive to peptide-specific lysis by neighboring T cells after acquisition of MHC I:peptide complexes from APCs (18, 19) . Also, naive T cells that had acquired CD80 from APC were capable of inducing IL-2 production by responder T cells (21) .
For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From
The results described extend these findings by showing that the presentation of acquired MHC II:peptide complexes has the same functional effects that have been observed using human T cells that express endogenously synthesised MHC class II molecules. In previous studies in a human system we have described heterogeneity amongst T cell clones, such that T:T antigen presentation by some clones induces apoptosis, while for other clones the dominant effect is the induction of anergy. Using a T cell line derived from DO11.10 TCR-transgenic mice, the presentation of acquired MHC class II:peptide complexes induced both apoptosis and anergy. peptide. To isolate 3A9 cells from the co-culture, 3A9 cells which were CFSE negative, were sorted. The sorted 3A9 cells, devoid of any APC, were then cultured in medium.
The sorted 3A9 cells were stained simultaneously with cy-chrome-conjugated anti-CD4
and PE-conjugated anti-H2-A k at different time intervals. The level of H2-A k on 3A9 was analysis by flow cytometry. Only the CD4 + population was gated for analysis. 
